BSE & NSE
01 Sep - 03 Sep '21
₹603 - ₹610
Having been in business since 2004, Ami Organics Limited serves as one of the country’s research and development-oriented manufacturers responsible for creating certain chemicals. Manufactured products made by AMI Organics include a wide range of advanced pharmaceutical intermediates along with active pharmaceutical ingredients. Each of these is relevant for new chemical entities and are also used in agrochemicals and fine chemicals. Presently, the company boasts of over 450 pharma intermediates that it has developed to be used across 17 prominent therapeutic areas. Among these include anti-depressants, anti-cancer, anti-inflammatory and anti-coagulant.
AMI Organics IPO details are as follows.
AMI Organics IPO date opened on September 1, 2021 and closed on September 3, 2021.
The AMI Organics IPO share price fell in the range of INR 603 to INR 610 per equity share.
The market lot for this IPO amounted to 24 shares. Retail individual investors were allowed to apply for up to 13 lots.
This means that at most a retail individual investor could hold 312 shares valued at INR 190,320.
AMI Organics makes for a viable investment as its speciality chemicals have been well received thus far. This is evident from its customers who amount to over 150. Presently exports contribute significantly to the company’s revenue. These exports have grown by 21.8 per cent (annualised rate) in the period between FY 2019 and FY 2021.
When looking at certain pharma intermediaries like Dolutegravir, Nintedanib and Entacapone, AMI Organics is one of the leading manufacturers.
The company boasts of an extensive global presence and caters to diverse customers.
It has showcased consistent financial performance.
The fact that AMI Organics is dependent on certain therapeutic areas to derive a vast chunk of its revenue weakens it. Thus far, the company has been unable to identify and understand the evolution within industry trends.
All of its manufacturing facilities are geographically concentrated in the state of Gujarat.
The business AMI Organics is involved in is capital intensive.
AMI Organics has acquired two plants (Ankleshwar and Jhagadia) that previously belonged to Gujarat Organics Ltd in March this year for INR 93 Crores. This investment has allowed them to hold three plants with a working capacity of 6060 million tonnes per annum in their entirety.
These new plants will allow the company to expand its offerings and capabilities in the near future, thereby potentially generating more revenue.
Serving as a threat to its output is the operations it conducts within a hazardous industry. Operational risks, for instance, pertain to the storage, manufacture, and usage of a number of hazardous materials.
You can apply for the AMI Organics Ltd. IPO in these ways:
Link your personal bank A/C to a trusted UPI ID and map it with your TradeSmart account. Now, proceed further to book your IPO. On acceptance of the mandate, the bid amount will get blocked in your bank account Learn more.
What was the share price of the AMI Organics IPO?
The AMI Organics IPO price fell in the range of INR 603 to INR 610 per equity share.
What are AMI Organics IPO details pertaining to the dates of said IPO?
The AMI Organics IPO dates fell between September 1 and September 3, 2021.
What was the issue size of the AMI Organics IPO?
The issue size of the AMI Organics IPO was INR 569.63 Crores.
What was the subscription rate of the AMI Organics IPO?
The subscription rate for the AMI Organics IPO was as follows.
The retail individual investor category subscribed 13.36 times.
The non-institutional investor category subscribed 154.81 times.
The qualified institutional buyer category subscribed 86.64 times.